CoChat

The Impact of Centers for Medicare & Medicaid Services SEP-1 Core Measure Implementation on Antibacterial Utilization: A Retrospective Multicenter Longitudinal Cohort Study With Interrupted Time-Series Analysis

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Background: The impact of the US Centers for Medicare & Medicaid Services (CMS) Severe Sepsis and Septic Shock: Management Bundle (SEP-1) core measure on overall antibacterial utilization is unknown. Methods: We performed a retrospective multicenter longitudinal cohort study with interrupted time–series analysis to determine the impact of SEP-1 implementation on antibacterial utilization and patient outcomes. All adult patients admitted to 26 hospitals between 1 October 2014 and 30 September 2015 (SEP-1 preparation period) and between 1 November 2015 and 31 October 2016 (SEP-1 implementation period) were evaluated for inclusion. The primary outcome was total antibacterial utilization, measured as days of therapy (DOT) per 1000 patient-days. Results: The study cohort included 701 055 eligible patient admissions and 4.2 million patient-days. Overall antibacterial utilization increased 2% each month during SEP-1 preparation (relative rate [RR], 1.02 per month [95% confidence interval {CI}, 1.00–1.04]; P = .02). Cumulatively, the mean monthly DOT per 1000 patient-days increased 24.4% (95% CI, 18.0%–38.8%) over the entire study period (October 2014–October 2016). The rate of sepsis diagnosis/1000 patients increased 2% each month during SEP-1 preparation (RR, 1.02 per month [95% CI, 1.00–1.04]; P = .04). The rate of all-cause mortality rate per 1000 patients decreased during the study period (RR for SEP-1 preparation, 0.95 [95% CI, .92–.98; P = .001]; RR for SEP-1 implementation, .98 [.97–1.00; P = .01]). Cumulatively, the monthly mean all-cause mortality rate/1000 patients declined 38.5% (95% CI, 25.9%–48.0%) over the study period. Conclusions: Announcement and implementation of the CMS SEP-1 process measure was associated with increased diagnosis of sepsis and antibacterial utilization and decreased mortality rate among hospitalized patients.

Overview

Integrity signals

Registry

Crossref · 10.1093/cid/ciab937

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Cited by

See all 19

Metadata

Authors
Anderson, D. J., Moehring, R. W., Parish, A., David, M. Z., Hsueh, K., Cressman, L., Tolomeo, P., Habrock-Bach, T., Hill, C. L., Ryan, M., O’Brien, C., Lokhnygina, Y., & Dodds Ashley, E.
Affiliations
  • Duke University (US)
  • University of Pennsylvania (US)
  • Washington University in St. Louis (US)
  • Duke Medical Center (US)
  • Duke Center for Antimicrobial Stewardship and Infection Prevention , Durham, North Carolina , USA
Corresponding author
Anderson, Deverick J
Venue
Clinical Infectious Diseases
Published
2021-11-05
Volume
75
Issue
3
Pages
503-511
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W3208106284
Cited by
19
References
28
Citations by year
2026: 1 · 2025: 6 · 2024: 3 · 2023: 6 · 2022: 3
FWCI
1.76
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
Centers for Disease Control and Prevention (U54CK000483)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
Keywords
days of therapy, sepsis diagnosis, all-cause mortality, quality metrics, process indicators, antimicrobial stewardship, hospital quality improvement, Medicare reimbursement policy
MeSH terms
Adult, Aged, Anti-Bacterial Agents, Medicare, Humans, Longitudinal Studies, Medicaid, Retrospective Studies, United States, Cohort Studies, Sepsis, Patient Care Bundles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Impact of Centers for Medicare & Medicaid Services SEP-1 Core Measure Implementation on Antibacterial Utilization: A Retrospective Multicenter Longitudinal Cohort Study With Interrupted Time-Series Analysis. https://app.cochat.ai/papers/10.1093/cid/ciab937
The paper
Anderson, D. J., Moehring, R. W., Parish, A., David, M. Z., Hsueh, K., Cressman, L., Tolomeo, P., Habrock-Bach, T., Hill, C. L., Ryan, M., O’Brien, C., Lokhnygina, Y., & Dodds Ashley, E. (2022). The Impact of Centers for Medicare & Medicaid Services SEP-1 Core Measure Implementation on Antibacterial Utilization: A Retrospective Multicenter Longitudinal Cohort Study With Interrupted Time-Series Analysis. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciab937

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.